(Q30804405)

26 June 2017

title

Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route (English)

1 reference

26 June 2017

Alejandro D Montaner

1

1 reference

26 June 2017

Analía De Nichilo

2

1 reference

26 June 2017

Fernanda Elias

3

1 reference

26 June 2017

Juan M Rodríguez

4

1 reference

26 June 2017

Juan M Fló

5

1 reference

26 June 2017

Ricardo A López

6

1 reference

26 June 2017

Jorge Zorzopulos

7

1 reference

26 June 2017

Ronald Frank

8

1 reference

26 June 2017

language of work or name

English

0 references

publication date

7 November 2005

1 reference

26 June 2017

1 reference

26 June 2017

volume

24

1 reference

26 June 2017

issue

11

1 reference

26 June 2017

page(s)

1889-1896

1 reference

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Selection of ganglioside GM1-binding peptides by using a phage library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

The Three-dimensional Crystal Structure of Cholera Toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

inferred from DOI database lookup

7 January 2021

based on heuristic

Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.037

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.10.037

1 reference

26 June 2017

1 reference